Documentos relacionados

1. [Cold agglutinin disease: pathology, diagnosis, and treatment].
2. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
3. Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).
4. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
5. Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
6. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
7. Warm autoimmune hemolytic anemia: new insights and hypotheses.
8. Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
9. Ultrastructural analysis of nucleated erythrocyte in patients with autoimmune hemolytic anemia (AIHA).
10. Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.